Latest disclosed round
Accelerator / portfolio record
- Date
- Not stated
- Amount
- Not stated
- Sector
- Biotech & techbio; Healthtech & digital health
- Companies House
- Not linked
Other / review
Ochre Bio
Developing RNA medicines for chronic liver disease.
ReviewPortfolio stage not normalizedLondon
Evidence status
Review retained
- Identity
- Review
- Match
- Portfolio-verified UK scope; legal identity unresolved
- Operating status
- Official portfolio/cohort record; operating status not independently checked
- Data origins
- Growth Network
Capital network
0 linked investors
No investor relationship retained.
Funding record
0 disclosed rounds
| Date | Stage | Amount | Investors |
|---|---|---|---|
| No round-level record retained. | |||
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.